EndoChoice CEO buys 20k shares of company stock: 5 takeaways

EndoChoice CEO Mark Gilreath bought 20,000 shares of the company’s stock, according to a South Florida Hedge Fund Managers report.

Advertisement

Here are five takeaways:

1. The shares were purchased at an average price of $5.06 per share, for a total value of $101,200.

2. The CEO now owns 753,250 shares of the company’s stock.

3. EndoChoice has a 52-week low of $3.70 and a 52-week high of $19.69.

4. The company’s 50-day moving average price is $4.81 and its 200-day moving average price is $8.81.

5. The company’s market capitalization is $143.81 million.

More articles on GI/endoscopy:
6 GI physicians in the news — March 18, 2016
Drs. Paul Fishbein, Vicente Lago join Gastro Health — 3 highlights
GI physician leader to know: Dr. Paul Lebovitz of Allegheny Health Network

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.